Oncotype DX breast testing
Ended Awarded
- Contract number
- HT001419F0244
- Awardee
-
Genomic Health, Inc. UEI RHN3L7SBF7J6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $13,815
Award facts
- Contract value 100% obligated
- $13,815.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Los Angeles, CA 90074, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HT001419F0244?
HT001419F0244 was awarded to Genomic Health, Inc. by Defense Health Agency (Department of Defense) on March 27, 2019.
How much is contract HT001419F0244 worth?
The government has obligated $13,815 on HT001419F0244.
Is contract HT001419F0244 an order under another contract?
Yes. HT001419F0244 is a BPA call under HT001416A0144, a blanket purchase agreement.
Was contract HT001419F0244 competed?
The extent of competition for HT001419F0244 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award